K. Sachs-Barrable

发表

Tacrolimus-Induced Elevation in Plasma Triglyceride Concentrations After Administration to Renal Transplant Patients Is Partially Due to a Decrease in Lipoprotein Lipase Activity and Plasma Concentrations

John S. Hill, Caylee-Britt Goshko, K. Wasan, 2009, Transplantation.

Suitability of LLC-PK1 pig kidney cells for the study of drug action on renal cell cholesterol uptake: identification and characterization of low-density lipoprotein receptors.

K. Wasan, Stephen D. Lee, K. Sachs-Barrable, 2005, Journal of pharmacological and toxicological methods.

Acute P-407 Administration to Mice Causes Hypercholesterolemia by Inducing Cholesterolgenesis and Down-Regulating Low-Density Lipoprotein Receptor Expression

K. Wasan, T. Johnston, C. Leon, 2006, Pharmaceutical Research.

Hepatic lipase deficiency in a Middle-Eastern-Arabic male

R. Hegele, John S. Hill, J. Frohlich, 2010, BMJ Case Reports.

Hepatic lipase deficiency in a Middle-Eastern-Arabic male

R. Hegele, J. Frohlich, K. Wasan, 2010, BMJ Case Reports.

Poloxamer 407 (P-407)-mediated reduction in the gene expression of ATP-binding-cassette transporter A1 may contribute to increased cholesterol in peripheral tissues of P-407-treated rats.

M. Jaye, K. Wasan, T. Johnston, 2006, European journal of pharmacology.

Evaluation of the contribution of the ATP binding cassette transporter, P-glycoprotein, to in vivo cholesterol homeostasis.

K. Wasan, Stephen D. Lee, Sheila J. Thornton, 2013, Molecular pharmaceutics.

Lanthanide containing compounds for therapeutic care in bone resorption disorders.

K. Wasan, C. Orvig, K. Thompson, 2007, Dalton transactions.

Potential Mechanisms by Which Peceol® Increases the Gastrointestinal Absorption of Amphotericin B

Michael Boyd, K. Wasan, Verica Risovic, 2004, Drug development and industrial pharmacy.

Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections.

E. Wasan, K. Wasan, Kristina Sachs-Barrable, 2008, Advanced drug delivery reviews.

The use of the United States FDA programs as a strategy to advance the development of drug products for neglected tropical diseases

Fady Ibrahim, P. Gershkovich, K. Wasan, 2014, Drug development and industrial pharmacy.

In vitro studies of lanthanide complexes for the treatment of osteoporosis.

K. Wasan, C. Orvig, J. Cawthray, 2013, Dalton transactions.

Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery

Dion R. Brocks, D. Brocks, K. Wasan, 2008, Nature Reviews Drug Discovery.

Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.

K. Wasan, Kristina Sachs-Barrable, Kishor M Wasan, 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within Caco-2 cells

K. Wasan, J. W. Darlington, K. Sachs-Barrable, 2014, Lipids in Health and Disease.

The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within Caco-2 cells

K. Wasan, J. W. Darlington, K. Sachs-Barrable, 2014, Lipids in Health and Disease.

Cyclosporine A and Rapamycin induce in vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma.

K. Wasan, Rita Tory, K. Sachs-Barrable, 2008, International journal of pharmaceutics.

Effects of monoglycerides on P-glycoprotein: modulation of the activity and expression in Caco-2 cell monolayers.

K. Wasan, Kristina Sachs-Barrable, Kishor M Wasan, 2008, Molecular pharmaceutics.

Does P-Glycoprotein Play a Role in Gastrointestinal Absorption and Cellular Transport of Dietary Cholesterol?

K. Wasan, C. Leon, K. Sachs-Barrable, 2006, Drug development and industrial pharmacy.